4//SEC Filing
ZIEGLER JOSEPH 4
Accession 0001209191-23-046702
CIK 0000025743other
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 4:22 PM ET
Size
5.2 KB
Accession
0001209191-23-046702
Insider Transaction Report
Form 4
ZIEGLER JOSEPH
Principal Financial Officer
Transactions
- Award
Common Stock
2023-08-17+7,500→ 7,500 total
Footnotes (1)
- [F1]These shares of common stock of the Issuer are to be acquired upon the vesting of restricted stock units ("RSUs") granted to the Reporting Person. The RSUs shall fully vest on the earlier of August 17, 2024 or a Change in Control of the Issuer (as defined in the Issuer's 2019 Stock Incentive Plan).
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001979286
Filing Metadata
- Form type
- 4
- Filed
- Aug 20, 8:00 PM ET
- Accepted
- Aug 21, 4:22 PM ET
- Size
- 5.2 KB